amikacin has been researched along with Arthritis, Rheumatoid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, M; Betsuyaku, T; Hasegawa, N; Ishii, M; Kohno, M; Namkoong, H; Suzuki, K; Takeuchi, T; Tasaka, S; Yagi, K | 1 |
Berthelot, P; Carricajo, A; Lucht, F; Suy, F | 1 |
2 other study(ies) available for amikacin and Arthritis, Rheumatoid
Article | Year |
---|---|
Successful resumption of tocilizumab for rheumatoid arthritis after resection of a pulmonary Mycobacterium avium complex lesion: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Clarithromycin; Ethambutol; Female; Humans; Immunocompromised Host; Lung; Middle Aged; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Rifampin; Tomography, X-Ray Computed | 2015 |
[Misleading improvement of abdominal tuberculosis with amikacin, within 72 hours].
Topics: Adrenal Cortex Hormones; Adult; Amikacin; Antirheumatic Agents; Antitubercular Agents; Arthritis, Rheumatoid; Drug Resistance, Microbial; Drug Therapy, Combination; Etanercept; Female; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Penicillanic Acid; Peritonitis, Tuberculous; Piperacillin; Piperacillin, Tazobactam Drug Combination; Receptors, Tumor Necrosis Factor; Recurrence; Streptomycin; Time Factors; Tuberculosis, Splenic | 2012 |